comparemela.com
Home
Live Updates
High Cost of Funds Presents Critical Challenge for Biotech Sector : comparemela.com
High Cost of Funds Presents Critical Challenge for Biotech Sector
Overall, for the biotech investor, I see very little value in big caps. The best prospects for growth are on the lower end.
Related Keywords
United States
,
United Kingdom
,
British
,
Steve Brozak
,
Columbia University
,
Drew University
,
Salomon Brothers
,
Cowen Company
,
High Cost
,
Funds Presents Critical Challenge
,
Managing Partner
,
Financial Times Industry Analyst
,
Wall Street Journal
,
Dean Witter
,
British Medical Journal
,
Medical Humanities
,
United States Marine Corps
,
comparemela.com © 2020. All Rights Reserved.